Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Nitric Oxide After Cardiac Surgery (Right Ventricular Function and Pulmonary Vascular Mechanics)
2025-520808-10-00Phase 3Authorised
- Sponsor
- Fundación de Investigación Biomédica del Hospital Universitario de La Princesa
- Start
- Jan 2025
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of nitric oxide in Postcardiac surgery state, Right heart dysfunction (RHF) and pulmonary hypertension (PH), sponsored by Fundación de Investigación Biomédica del Hospital Universitario de La Princesa. Planned start Jan 2025; status: authorised.
02
Drugs
nitric oxide
03
Conditions
Postcardiac surgery stateRight heart dysfunction (RHF)pulmonary hypertension (PH)
Beyond the preview
Go deeper on 2025-520808-10-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-520808-10-00.